Signe Egstrand D.

Signe Egstrand D. has over 10 years of experience in the pharmaceutical industry. Signe Egstrand currently works as a Global Regulatory Project Lead at Y-mAbs Therapeutics, Inc. since September 2020. Prior to this, they were a Regulatory Affairs Manager at Coloplast from May 2017 to June 2020. Before that, they worked at Novo Nordisk as a Regulatory Professional from November 2012 to April 2017. At Novo Nordisk, they were responsible for coordinating and executing regulatory tasks, preparing quality sections of regulatory files, and maintaining regulatory files in collaboration with stakeholders. From April 2010 to October 2012, Signe worked as a Global Regulatory Affairs Associate at Ferring Pharmaceuticals, where they were responsible for regulatory activities in Asia and EU, including submitting and maintaining clinical trial applications and reviewing clinical trial protocols and reports.

Signe Egstrand D. began their education in 2004 at Danmarks Farmaceutiske Universitet, where they pursued a degree in Pharmacy. Signe Egstrand studied at this institution until 2010, during which time they completed their Master of Science in Pharmacy. In the same period, they also attended Københavns Universitet - University of Copenhagen, where they obtained a degree in Pharmacy known as Cand.Pharm. Signe Egstrand D.'s educational background is focused on the field of Pharmacy, having completed their studies in this subject at both universities.